Navigation Links
Robin C. Stracey Joins Cantimer, Inc. as President and CEO
Date:12/17/2007

Vice President and General Manager of an analytical instrument business unit at Thermo Electron Corporation. He joined Thermo Electron from Dade Behring Inc., where he was a Corporate Vice President with general management responsibility for Syva Company, a leading supplier of specialized diagnostic systems and reagents. His early career included a variety of sales, commercial marketing and strategy development positions of increasing responsibility in DuPont's Medical Products Department. Mr. Stracey has a Bachelor of Science degree with honors from the University of Nottingham in the United Kingdom and is a graduate of the Executive Program at the Stanford University Graduate School of Business.

"I am very excited about Cantimer's prospects," noted Stracey. "The Company's technology is elegant and has broad potential application in a number of large markets where accurate, rapid detection and measurement of analytes is important. The initial focus on hydration measurement will create a new and much needed capability within health care," he added.

About Cantimer

Cantimer is a privately-held development stage company commercializing a patented, proprietary sensor technology platform having applications in life science, health care, bio-defense and consumer markets. The technology will initially be embodied into point-of-care products for convenient, non-invasive, measurement and monitoring of human hydration status using saliva as a sample.


'/>"/>
SOURCE Cantimer, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
2. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. Hank Plain Joins Morgenthaler Ventures as Partner
5. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
6. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
7. Dan Broderick Joins Prolog Ventures as Partner
8. Ingenuity Systems Joins Biomarkers Consortium
9. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
10. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
11. Progeniq Joins Microsoft in Bio IT Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Efficient Construction of Synthetic Genomes , ...re/ -- Researchers at the J. Craig Venter Institut...zation, have published a paper describing a signif... can now assemble the whole bacterial genome, Myc... of DNA. Lead author Daniel G. Gibson, Ph.D. and h...
(Date:12/4/2008)...rate research of potential vaccine for low-resourc...Md., Dec. 4 The biotech company Le... organization PATH announced today a partnership t...ine. PATH will initially invest $3 million over 27...lopment of a H5N1 virus-like particle (VLP) protot...
(Date:12/4/2008)...swire-FirstCall/ -- NeoStem, Inc.,(NYSE Alternext...lection,processing and long-term storage of adul...nced that it has reached a major milestone in its ...st ever collection center for collection of,adult...al need in New York,City and has chosen Bruce Yaf...
(Date:12/4/2008)...c. 4 A 60-year-old,pros...e first person in France,to be treated using Rapi...NYSE: VAR ) for fast and precise forms of intens...eatments at the CRLC Val D,Aurelle - Paul Lamarque...faster than conventional IMRT,treatments. Dr. Pas...
Breaking Biology Technology:J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 2J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 3J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 4J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 5Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3
...ADISON - A homegrown software innovation born of "... Mass Communications at the University of Wisconsi...rs to a new world of online survey research. , ,"I...id pace, and also allows us to bring technology in...hah, associate professor of journalism. "It,s beco...
...ADISON, WI. - TDS Metrocom and Internet Photonic...net Photonics, LightStack Intelligent Wavelength p...prise customers and service providers. The service... protected connections in retail and wholesale app...ta products for TDS Metrocom, GigaDATA provides a ...
...The Wisconsin Technology Network has received from...e report, which contains a primer for Wisconsin co...ilable in the state. David Ward and his team have ...-installments on WTN. Todays forth and final insta...Seed-Stage Financings are often comparatively mod...
...s an attorney who works with several technology-ba...t how to obtain outside financing. One source tha...h the federal Small Business Innovation Research (...ograms. While I do not provide clients with assis...tly field questions pertaining to eligibility requ...
Other Biology Technology:UW Journalism School Software Expands Web-Based Research 2UW Journalism School Software Expands Web-Based Research 3Seed-Stage Venture Financing 2Seed-Stage Venture Financing 3Seed-Stage Venture Financing 4Seed-Stage Venture Financing 5SBIR/STTR Programs: Free Money or an Invitation to Governmental Bureaucracy 2SBIR/STTR Programs: Free Money or an Invitation to Governmental Bureaucracy 3
(Date:12/4/2008)... defences and causes disease,by sneakily disabli...ealed in new research out today (4 December) in C...pathogen which causes bacterial speck disease,in ...k lesions on leaves,and fruit. Severe infection c...ops, and researchers believe that understanding mo...
(Date:12/4/2008)...namis over the past four years is not enough to sp...an international group of earthquake researchers i... journal Nature . , The first of the recent gre...produced the most widespread and destructive tsuna...as the rupture of a 1600-km-long piece of the Sund...
(Date:12/3/2008)... BIO-key International, Inc.,(OTC Bulletin Board:...ication,and wireless public safety, announced tod...approved the issuance of a patent for the company,...ecurity System" method. , The benefits of t...ber,7,454,624) provide another layer of defense a...
(Date:12/3/2008)...st 5-year forest inventory report for California,s...public: California,s Forest Resources, 2001-2005: ...Here are some key findings from the report:, , ...lion acres;19 million acres is publicly managed. ,...ount for most of the housing growth in the state o...
Breaking Biology News(10 mins):Red alert! How disease disables tomato plant's 'intruder alarm' 2September 2007 Sumatran earthquakes research findings 2September 2007 Sumatran earthquakes research findings 3BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2Forest inventories in California include more than trees 2Forest inventories in California include more than trees 3NutraCea Announces Third Quarter 2008 Conference Call 28698 1Too Many High Risk Teens Not Getting Flu Shots 28695 1Too Many High Risk Teens Not Getting Flu Shots 28695 2Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call 8871 1Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call 8871 2OncoMed Pharmaceuticals Completes Series B Financing 8868 1OncoMed Pharmaceuticals Completes Series B Financing 8868 2OncoMed Pharmaceuticals Completes Series B Financing 8868 3
... University School of Medicine have taken a first ...that could eventually be transplanted into living ...rived from mice, surgical resident Oscar Abilez, M... the stem cells into myocytes, one of the building...life-like growth environment that the research tea...
...nique of distraction has been researched and succe...educe pain associated with certain medical procedu...tion that there is an important psychological elem...attention given to the harmful stimulus affecting ...ques are based on the patient,s limited capacity f...
...y of York have made a huge leap forward in the sea...p in the Department of Biology has made a signific...eins to conduct a type of biological warfare. , ...other when resources are scarce using protein anti... , The research led by Professor Colin Kleanthou...
...rmal breast cells cancerous by blocking their abil...mor development, University of Florida scientists ...are able to fix their damaged DNA, many others bec...kit, according to findings from a UF study publish...y survive long enough to divide and multiply, they...
Other Biology News:Stanford doctors advance in bid to turn mice stem cells into blood vessels 2Stanford doctors advance in bid to turn mice stem cells into blood vessels 3Virtual realities against pain 2Cigarette smoke blocks cell repair mechanism, University of Florida study shows 2Cigarette smoke blocks cell repair mechanism, University of Florida study shows 3
...e cloning of BAC (100+kb), fosmid (40kb), and larg...ability than any othe BAC vector. On command 20-50...recombinant DNA purification. Available with blue-...SMART VC) vectors for the highest insert stability...
RABBIT ANTI GLYCINE
... Diagnostics Cytomegalovirus (CMV) pp65 Antigenemi...he qualitative identification of lower matrix prot...cytes. Kit Components: Erythrocyte Lysis Buff...mL of buffered ammonium chloride. (NH4CL) Fixatio...
For use with suspension (non-adherent) cells, RNA ture RiboCap™ uses vacuum filtration or centrifugation to separate cells from culture media. Compatible with 96-well GenePlate®. RiboCap
Biology Products: